Cargando…
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
The identification of a novel β coronavirus, nCoV, as the causative agent of severe respiratory illness in humans originating in Saudi Arabia, Qatar and Jordan has raised concerns about the possibility of a coronavirus pandemic similar to that of SARS-CoV. As a definitive treatment regimen has never...
Autores principales: | Falzarano, Darryl, de Wit, Emmie, Martellaro, Cynthia, Callison, Julie, Munster, Vincent J., Feldmann, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629412/ https://www.ncbi.nlm.nih.gov/pubmed/23594967 http://dx.doi.org/10.1038/srep01686 |
Ejemplares similares
-
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
por: Falzarano, Darryl, et al.
Publicado: (2013) -
206: Transcriptional signatures of pathogenesis and successful type I interferon and ribavirin therapy in a rhesus macaque model of MERS-CoV infection
por: Rasmussen, Angela L., et al.
Publicado: (2013) -
An Acute Immune Response to Middle East Respiratory Syndrome Coronavirus Replication Contributes to Viral Pathogenicity
por: Baseler, Laura J., et al.
Publicado: (2016) -
SARS and MERS: recent insights into emerging coronaviruses
por: de Wit, Emmie, et al.
Publicado: (2016) -
The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters
por: de Wit, Emmie, et al.
Publicado: (2013)